Literature DB >> 3571460

Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.

D K Wagner, M L Clements, C B Reimer, M Snyder, D L Nelson, B R Murphy.   

Abstract

Following intranasal administration of live influenza A virus vaccine or parenteral inoculation of inactivated influenza virus vaccine, immunoglobulin antibody to the influenza virus hemagglutinin was detected in nasal wash specimens from adult volunteers. Several observations supported the suggestion that this immunoglobulin G hemagglutinin nasal wash antibody appeared to be mainly derived from the serum by a process of passive transudation.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3571460      PMCID： PMC265990          DOI： 10.1128/jcm.25.3.559-562.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Antibody response in respiratory secretions of volunteers given live and dead influenza virus.

Authors:  J J Mann; R H Waldman; Y Togo; G G Heiner; A T Dawkins; J A Kasel
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

3.  Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes.

Authors:  C B Reimer; D J Phillips; C H Aloisio; D D Moore; G G Galland; T W Wells; C M Black; J S McDougal
Journal:  Hybridoma       Date:  1984

4.  Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.

Authors:  J M Zahradnik; J A Kasel; R R Martin; H R Six; T R Cate
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

5.  IgA subclasses in various secretions and in serum.

Authors:  D L Delacroix; C Dive; J C Rambaud; J P Vaerman
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

6.  Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.

Authors:  P R Johnson; S Feldman; J M Thompson; J D Mahoney; P F Wright
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

7.  Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

Authors:  B R Murphy; D L Nelson; P F Wright; E L Tierney; M A Phelan; R M Chanock
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats.

Authors:  G A Prince; R L Horswood; R M Chanock
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.

Authors:  P R Johnson; S Feldman; J M Thompson; J D Mahoney; P F Wright
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

10.  Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.

Authors:  D K Wagner; B S Graham; P F Wright; E E Walsh; H W Kim; C B Reimer; D L Nelson; R M Chanock; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948
View more
  45 in total

1.  An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.

Authors:  Yuk-Fai Lau; Lay-Hoon Tang; Amber W McCall; Eng-Eong Ooi; Kanta Subbarao
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.

Authors:  E T Ben Ahmeida; R Jennings; M Erturk; C W Potter
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine.

Authors:  B D Forrest; J T LaBrooy; P Robinson; C E Dearlove; D J Shearman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Protective effect of serum antibody on respiratory infection of influenza C virus in rats.

Authors:  K Takiguchi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

7.  Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice.

Authors:  M Tashiro; K Tobita; J T Seto; R Rott
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.

Authors:  Attapon Kamlangdee; Brock Kingstad-Bakke; Jorge E Osorio
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.

Authors:  Peter T Loudon; Eric J Yager; Debbie T Lynch; Amithi Narendran; Cristy Stagnar; Anthony M Franchini; James T Fuller; Phil A White; Julia Nyuandi; Clayton A Wiley; Michael Murphey-Corb; Deborah H Fuller
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.